Novembre E, Calogero C, Mori F, Bernardini R, Pucci N, Bonini M, Vierucci A, De Martino M
Allergy and Clinical Immunology Unit, Azienda Ospedaliero Universitaria A. Meyer, Via L. Giordano 13, 50132 Florence, Italy.
Int J Immunopathol Pharmacol. 2006 Apr-Jun;19(2):449-50. doi: 10.1177/039463200601900223.
Ketorolac tromethamine is a recent injectable non-steroidal anti-inflammatory drug (NSAID) with analgesic properties approved for short-term pain management. In spite of its increasing use both in adults and children, relatively few allergic-like reactions have been reported. Reactions are often severe, and a death occurred following an intramuscular injection of ketorolac.
酮咯酸氨丁三醇是一种近期获批用于短期疼痛管理的具有镇痛特性的注射用非甾体抗炎药(NSAID)。尽管其在成人和儿童中的使用日益增加,但报告的过敏样反应相对较少。反应通常较为严重,有一例在肌内注射酮咯酸后发生了死亡。